Skip to Content
Merck
CN

A6756

Sodium arsenate dibasic heptahydrate

≥98.0%

Synonym(s):

Disodium hydrogen arsenate heptahydrate, di-Sodium hydrogen arsenate heptahydrate

Sign In to View Organizational & Contract Pricing

Select a Size

About This Item

Linear Formula:
Na2HAsO4 · 7H2O
CAS Number:
10048-95-0
Molecular Weight:
312.01
MDL number:
MFCD00149179
UNSPSC Code:
12352302
PubChem Substance ID:
24891135
NACRES:
NA.21
Assay:
≥98.0%
Form:
powder

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Quality Level

200

Assay

≥98.0%

form

powder

reaction suitability

reagent type: catalyst
core: arsenic

pH

8.5-9.0 (25 °C, 50 g/L)

SMILES string

O.O.O.O.O.O.O.[Na+].[Na+].O[As]([O-])([O-])=O

InChI

1S/AsH3O4.2Na.7H2O/c2-1(3,4)5;;;;;;;;;/h(H3,2,3,4,5);;;7*1H2/q;2*+1;;;;;;;/p-2

InChI key

KOLXPEJIBITWIQ-UHFFFAOYSA-L

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Sodium arsenate dibasic heptahydrate (As(V)) is an arsenic compound.

Application

Sodium arsenate dibasic heptahydrate may be used as a reference standard for the quantification of arsenic compounds in rice- and seafood-based samples by ion chromatography-inductively coupled plasma/ mass spectrometry. The samples for analysis were prepared by ultrasonic-assisted enzymatic extraction (UAEE).

Signal Word

Danger

Hazard Statements

H301 + H331,H350,H410

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Carc. 1A

Storage Class Code

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

危险化学品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000513049
0000513049
0000507483
0000507483
0000500464

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Validation of a method for arsenic speciation in food by ion chromatography-inductively coupled plasma/mass spectrometry after ultrasonic-assisted enzymatic extraction.
Dufailly V, et al.
Journal of AOAC (Association of Official Analytical Chemists) International, 94(3), 947-958 (2011)
Shugo Suzuki et al.
Toxicology, 299(2-3), 155-159 (2012-06-06)
Inorganic arsenic is a known human carcinogen, inducing tumors of the skin, urinary bladder and lung. It is metabolized to organic methylated arsenicals. 2,3-Dimercaptopropane-1-sulfonic acid (DMPS), a chelating agent, is capable of reducing pentavalent arsenicals to the trivalent state and
Takayuki Watanabe et al.
Archives of toxicology, 85(6), 577-588 (2011-05-04)
It has been suggested that arsenic (+3 oxidation state) methyltransferase (AS3MT) plays a critical role in methylation of arsenic, and that arsenic-glutathione conjugate is a substrate for AS3MT-catalyzed methylation of arsenic. However, the mechanism of arsenic methylation in cells is
Lauren C Radlinski et al.
Cell chemical biology, 26(10), 1355-1364 (2019-08-14)
Aminoglycoside antibiotics require proton motive force (PMF) for bacterial internalization. In non-respiring populations, PMF drops below the level required for drug influx, limiting the utility of aminoglycosides against strict and facultative anaerobes. We recently demonstrated that rhamnolipids (RLs), biosurfactant molecules
Mark J Canet et al.
Drug metabolism and disposition: the biological fate of chemicals, 40(9), 1817-1824 (2012-06-16)
Nonalcoholic fatty liver disease (NAFLD) is represented by a spectrum of liver pathologies ranging from simple steatosis to nonalcoholic steatohepatitis (NASH). Liver damage sustained in the progressive stages of NAFLD may alter the ability of the liver to properly metabolize
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service